Here, we have demonstrated for the first time that EGF signalling is involved in the up-regulation of surface-localized alpha-enolase both in non-tumourigenic mammary epithelial cells and in breast cancer cells, independently from the steady-state level of surface expression and the metastatic potential of each cell type. Here, ENO1 is linked to breast cancer.